Cross-scale, cross-pathway evaluation using an agent-based non-small cell lung cancer model

Bioinformatics

Volumn 25, Issue 18, 2009, Pages 2389-2396

  Wang, Zhihui ^a   Birch, Christina M ^b   Sagotsky, Jonathan ^a   Deisboeck, Thomas S ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; CANCER INVASION; CANCER MODEL; COMPUTER MODEL; COMPUTER SIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; LUNG NON SMALL CELL CANCER; MOLECULAR DYNAMICS; PHENOTYPIC PLASTICITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR VOLUME;

COMPUTATIONAL BIOLOGY; EPIDERMAL GROWTH FACTOR; LUNG NEOPLASMS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 69849103228     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btp416     Document Type: Article

References (53)

1. Adjei,A.A. (2006) Novel combinations based on epidermal growth factor receptor inhibition. Clin. Cancer Res., 12, 4446s-4450s.
2. Akhurst,R.J. and Derynck,R. (2001) TGF-beta signaling in cancer - a double-edged sword. Trends Cell Biol., 11, S44-S51.
3. Albeck,J.G. et al. (2006) Collecting and organizing systematic sets of protein data. Nat. Rev., 7, 803-812.
4. Aldridge,B.B. et al. (2006) Physicochemical modelling of cell signalling pathways. Nat. Cell Biol., 8, 1195-1203.
5. Anumanthan,G. et al. (2005) Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells. Br. J. Cancer, 93, 1157-1167.
6. Armstrong,N.J. et al. (2006) A continuum approach to modelling cell-cell adhesion. J. Theor. Biol., 243, 98-113.
7. Blobe,G.C. et al. (2000) Role of transforming growth factor beta in human disease. N. Engl. J. Med., 342, 1350-1358.
8. Bru,A. et al. (2003) The universal dynamics of tumor growth. Biophys. J., 85, 2948-2961.
9. Chaplain,M.A. et al. (2001) Spatio-temporal pattern formation on spherical surfaces: Numerical simulation and application to solid tumour growth. J. Math. Biol., 42, 387-423.
10. Christley,S. et al. (2007) Patterns of mesenchymal condensation in amultiscale, discrete stochastic model. PLoS Comput. Biol., 3 e76.
11. Cui,W. et al. (1996) TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell, 86, 531-542.
12. De Jaeger,K. et al. (2004) Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer. Int. J. Radiat. Oncol. Biol. Phys., 58, 1378-1387.
13. Derynck,R. and Zhang,Y.E. (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature, 425, 577-584.
14. Di Ventura,B. et al. (2006) From in vivo to in silico biology and back. Nature, 443, 527-533.
15. Dittmar,T. et al. (2002) Induction of cancer cell migration by epidermal growth factor is initiated by specific phosphorylation of tyrosine 1248 of c-erbB-2 receptor via EGFR. FASEB J., 16, 1823-1825.
16. Dubin-Thaler,B.J. et al. (2004) Nanometer analysis of cell spreading on matrix-coated surfaces reveals two distinct cell states and STEPs. Biophys. J., 86, 1794-1806.
17. Edelstein-Keshet,L. and Ermentrout,G.B. (2001) A model for actin-filament length distribution in a lamellipod. J. Math. Biol. 43, 325-355.
18. Friedl,P. and Wolf,K. (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer, 3, 362-374.
19. Galle,J. et al. (2005) Modeling the effect of deregulated proliferation and apoptosis on the growth dynamics of epithelial cell populations in vitro. Biophys. J., 88, 62-75.
20. Gatenby,R.A. et al. (2006) Acid-mediated tumor invasion: A multidisciplinary study. Cancer Res., 66, 5216-5223.
21. Gerisch,A. and Chaplain,M.A. (2008) Mathematical modelling of cancer cell invasion of tissue: Local and non-local models and the effect of adhesion. J. Theor. Biol., 250, 684-704.
22. Gerlee,P. and Anderson,A.R. (2009) Evolution of cell motility in an individual-based model of tumour growth. J. Theor. Biol., 259 67-83.
23. Gupta,A.K. et al. (2004) Signaling pathways in NSCLC as a predictor of outcome and response to therapy. Lung, 182, 151-162.
24. Hanahan,D. and Weinberg,R.A. (2000) The hallmarks of cancer. Cell, 100, 57-70.
25. Hegedus,B. et al. (2000) Locomotion and proliferation of glioblastoma cells in vitro: Statistical evaluation of videomicroscopic observations. J. Neurosurg., 92, 428-434.
26. Hirsch,F.R. et al. (2003) Epidermal growth factor receptor in non-small-cell lung carcinomas: Correlation between gene copy number and protein expression and impact on prognosis. J. Clin. Oncol., 21 3798-3807.
27. Hood,J.D. and Cheresh,D.A. (2002) Role of integrins in cell invasion and migration. Nat. Rev. Cancer, 2, 91-100.
28. Janne,P.A. et al. (2005) Epidermal growth factor receptor mutations in non-small-cell lung cancer: Implications for treatment and tumor biology. J. Clin. Oncol., 23, 3227-3234.
29. Jemal,A. et al. (2008) Cancer statistics, 2008. CA Cancer J. Clin., 58, 71-96.
30. Khalil,I.G. and Hill,C. (2005) Systems biology for cancer. Curr. Opin. Oncol., 17, 44-48.
31. Kholodenko,B.N. et al. (1999) Quantification of short term signaling by the epidermal growth factor receptor. J. Biol. Chem., 274, 30169-30181.
32. Kiskowski,M.A. et al. (2004) Interplay between activator-inhibitor coupling and cell-matrix adhesion in a cellular automaton model for chondrogenic patterning. Dev. Biol., 271, 372-387.
33. Kronik,N. et al. (2008) Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics. Cancer Immunol. Immunother., 57, 425-439.
34. Lao,B.J. and Kamei,D.T. (2008) Investigation of cellular movement in the prostate epithelium using an agent-based model. J. Theor. Biol., 250, 642-654.
35. McClean,M.N. et al. (2007) Cross-talk and decision making in MAP kinase pathways. Nat. Genet., 39, 409-414.
36. McMahon,P.M. et al. (2008) Adopting helical CT screening for lung cancer: Potential health consequences during a 15-year period. Cancer 113, 3440-3449.
37. Melke,P. et al. (2006) A rate equation approach to elucidate the kinetics and robustness of the TGF-beta pathway. Biophys. J., 91, 4368-4380.
38. Mogilner,A. and Edelstein-Keshet,L. (2002) Regulation of actin dynamics in rapidly moving cells: A quantitative analysis. Biophys. J., 83, 1237-1258.
39. Postovit,L.M. et al. (2006) Influence of the microenvironment on melanoma cell fate determination and phenotype. Cancer Res., 66 7833-7836.
40. Price,J.T. et al. (1996) Epidermal growth factor (EGF) increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704. Eur. J. Cancer, 32A, 1977-1982.
41. Ramis-Conde,I. et al. (2008) Modeling the influence of the E-cadherin-beta-catenin pathway in cancer cell invasion: A multiscale approach. Biophys. J., 95, 155-165.
42. Ramis-Conde,I. et al. (2009) Multi-scale modelling of cancer cell intravasation: The role of cadherins in metastasis. Phys. Biol., 6, 16008.
43. Santos,S.D. et al. (2007) Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate. Nat. Cell Biol., 9, 324-330.
44. Schoeberl,B. et al. (2002) Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors. Nat. Biotechnol., 20, 370-375.
45. Siegel,P.M. and Massague,J. (2003) Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer, 3, 807-821.
46. Siegfried,J.M. (1987) Detection of human lung epithelial cell growth factors produced by a lung carcinoma cell line: Use in culture of primary solid lung tumors. Cancer Res., 47, 2903-2910.
47. Vilar,J.M. et al. (2006) Signal processing in the TGF-beta superfamily ligand-receptor network. PLoS Comput. Biol., 2, e3.
48. Wang,Z. et al. (2008) Cross-scale sensitivity analysis of a non-small cell lung cancer model: Linking molecular signaling properties to cellular behavior. Bio Syst., 92, 249-258.
49. Wang,Z. and Deisboeck,T.S. (2008) Computational modeling of brain tumors: Discrete, continuum or hybrid?, Sci. Model. Simulat., 15, 381-393.
50. Wang,Z. et al. (2007) Simulating non-small cell lung cancer with a multiscale agent-based model. Theor. Biol. Med. Model., 4, 50.
51. Xue,C. et al. (2006) Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis. Cancer Res. 66, 192-197.
52. Yingling,J.M. et al. (2004) Development of TGF-beta signalling inhibitors for cancer therapy. Nat. Rev. Drug Discov., 3, 1011-1022.
53. Zaman,M.H. et al. (2006) Migration of tumor cells in 3D matrices is governed by matrix stiffness along with cell-matrix adhesion and proteolysis. Proc. Natl Acad. Sci. USA, 103, 10889-10894.